Breast carcinoma in young patients

Lancet

Volumn 356, Issue 9235, 2000, Pages 1113-

  Ménard, Sylvie ^a   Casalini, Patrizia ^a   Cascinelli, Natale ^a   Balsari, Andrea ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; ESTROGEN RECEPTOR;

ADJUVANT CHEMOTHERAPY; ADULT; AGE; BREAST TUMOR; FEMALE; HUMAN; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NOTE; SURVIVAL; BREAST CANCER; BREAST CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER SURVIVAL; CLINICAL TRIAL; LETTER; MAJOR CLINICAL STUDY; ONSET AGE; PRIORITY JOURNAL;

ADULT; AGE FACTORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; FEMALE; FLUOROURACIL; HUMANS; METHOTREXATE; MIDDLE AGED; SURVIVAL ANALYSIS;

EID: 0034706134     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)74557-8     Document Type: Letter

References (4)

1. S Aebi S Gelber M Castiglione-Gertsch Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer? Lancet 355 2000 1869 1874
2. VF Guinee H Olsson T Moller Effect of pregnancy on prognosis for young women with breast cancer Lancet 343 1994 1587 1589
3. N Kroman J Wohlfahrt KW Andersen Time since childbirth and prognosis in primary breast cancer: population based study BMJ 315 1997 851 855
4. SH Olson AG Zauber J Tang Relation of time since last birth and parity to survival of young women with breast cancer Epidemiology 9 1998 669 671